NCT07488351 "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
| NCT ID | NCT07488351 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acibadem University |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-03-30 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-03-30 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Sufficient cognitive function to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology * Able and willing to provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension) * Severe cardiovascular or respiratory disease * Additional neurological or orthopedic conditions that may affect assessment performance * Severe visual or hearing impairment that could interfere with study assessments * Inability to cooperate with the physiotherapist during study assessments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07488351 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07488351 currently recruiting?
Yes, NCT07488351 is actively recruiting participants. Contact the research team at nuray.alaca@acibadem.edu.tr for enrollment information.
Where is the NCT07488351 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07488351 clinical trial?
NCT07488351 is sponsored by Acibadem University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.